Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
New research from King's College London suggests that a rapid blood testing method could deliver reliable results far more quickly than previously thought, potentially supporting faster and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results